期刊文献+

结节性红斑患者皮损中一氧化氮合酶、血管内皮生长因子的表达 被引量:2

Expression of nitric oxide synthase and vascular endothelial growth factor in lesions of patients with erythema nodosum
暂未订购
导出
摘要 目的 : 探讨一氧化氮合酶 (NOS)和血管内皮生长因子 (VEGF)在结节性红斑中的表达。方法 :用ABC免疫组化方法检测了 4 2例结节性红斑患者皮损和 15例正常人皮肤组织中NOS和VEGF。结果 :结节性红斑皮损中NOS和VEGF的检出率分别为 80 .95 %及 6 6 .6 7% ,阳性信号的表达与分布基本一致(χ2 =2 .2 2 <3.84 ,P >0 .5 ,u =0 .36 6 <0 .6 78,P >0 .5 ) ,主要位于表皮角质层和部分棘细胞、真皮及皮下脂肪层小血管内皮细胞和腺上皮细胞内 ,正常人皮肤组织中NOS和VEGF的表达微弱 ,分布于表皮角质层和部分棘细胞 ,真皮及皮下脂肪层未见。结论 : 结节性红斑皮损中有NOS和VEGF的强阳性表达 ,可能与病毒等微生物引起的免疫反应有关。 Objective:To measure the expression of nitri c oxide synthase (NOS) and vascular endothelial growth factor (VEGF) in patients with erythema nodosum. Methods: The expression and distribu tion of NOS and VEGF were detected by ABC immunohistochemistry technique in 42 c ases of erythema nodosum and 15 healthy controls. Results: In the group of patients,the detection rates of NOS and VEGF were 80.95% and 66 .67% respectively,and the positive expression and distribution were almost the same (χ 2=2.22<3.84,P>0.5,u=0.603<0.678,P>0.5),mainly in the stratum corneoum,parts of prickle cell layer of the epidermis,dermis and micro vascular endothelial cells and glandular epithelium of subcutaneous tissues. The expression of both NOS and VEGF were weak in healthy controls,mainly in parts of prickle cell layer and stratum corneoum of the epidermis,and no positive sig nal was found in dermal and subcutaneous tissues. Conclusion : Both NOS and VEGF were strongly expressed in erythema nodosum. This mayb e related to immunoreactivity of some microorganism infection such as virus,etc .
出处 《中国麻风皮肤病杂志》 北大核心 2004年第3期210-212,共3页 China Journal of Leprosy and Skin Diseases
关键词 结节性红斑 皮损 一氧化氮合酶 血管内皮生长因子 VEGF NOS 皮肤组织 erythema nodosum nitric oxide synthase (N OS) vascular endothelial growth factor (VEGF)
  • 相关文献

参考文献10

  • 1Gross SS, Wolin MS. Nitric oxide: pathophysiological mechanism.Annu Rev Phyciol 1995;57:737 - 769.
  • 2Yokoyama K, Mitomi H, Kobayashi K, et al. Obliterative arteritis with nitric oxide synthase and HLA - DR expression in Crohn' s colitis. Hepatogastroenterology 2001 ;48:401 - 407.
  • 3Jozkowicz A, Cooke JP, Guevara I, et al. Genetic augmentation of nitric oxide synthase increases the vascular generation of VEGF. Cardiovasc Res 2001 ;51:773 - 834.
  • 4Lal BK, Varma S, Pappas PJ, et al. VEGF increases permeability of the endothelial cell monolayer by activation of PKB/akt, endothelial nitric - oxide synthase, and MAP kinase pathways. Microvasc Res 2001 ;62:252 - 262.
  • 5Topaloglu R, Sungur A, Baskin E, et al. Vascular endothelial growth factor in Henoch - Schonlein purpura. J Rheumatol 2001 ; 28: 2269 -2273.
  • 6Brown LF, Harrist TJ, Yeo KT, et al. Increased expression of vascular permeability factor (vascular endothelial growth factor) in bullous pemphigoid, dermatitis herpetifonnis, and erythema multiforme. J Invest Dermatol. 1995;104:744- 749.
  • 7崔荣,张忠祥,党双锁,高丽琴,陈金穆.原位PCR法检测结节性红斑皮损组织中TBDNA、HSVⅡDNA、CMVDNA[J].中华微生物学和免疫学杂志,1999,19(5):436-439. 被引量:4
  • 8Lee DH, Cho HJ, Kim JT, et al. Expression of vascular endothelial growth factor and inducible nitric oxide synthase in pterygia. Cornea 2001 ;20:738 - 742.
  • 9Viac J, Palacio S, Schmitt D, et al. Expression of vascular endothelial growth factor in normal epidermis, epithelial tumors and cultured keratinocytes. Arch Dermatol Res 1997;289:158 - 163.
  • 10Shimizu Y, Sakai M, Umemura Y, et al. Immunohistochemical localization of nitric oxide synthase in normal human skin: expression of endothelial - type and inducible - type nitric oxide synthase in kerafinoeytes. J Dermatol. 1997;24:80- 87.

二级参考文献5

  • 1屈冰心.多形性红斑与单纯疱疹病毒关系的研究进展[J].国外医学(皮肤性病学分册),1994,20(5):269-272. 被引量:1
  • 2黄正吉 杨国亮 等.Behcet病.现代皮肤病学[M].上海:上海医科大学出版社,1996.701-705.
  • 3黄正吉,现代皮肤病学,1996年,701页
  • 4屈冰心,国外医学.皮肤性病学分册,1994年,20卷,269页
  • 5Komminoth P,Virchows Arch,1993年,64卷,67页

共引文献3

同被引文献19

  • 1王红,杨培增,彭晓燕,赵萌,周红颜,黄祥坤.Behet病患者结节红斑组织中CD40/CD40L共刺激分子的表达(英文)[J].国际眼科杂志,2007,7(4):883-886. 被引量:3
  • 2Kralj D, Ceroved M, Anic B. Etiology of erythema nodosum in rheumatology outpatient clinic. Lijec Vjesn, 2011,133 ( 11 - 12 ) :370-376.
  • 3Kisawk B, Onat AM, Pelilivan Y. Muhiclinical experiences inerythema nodosum: rheumatology clinics versus dermatology and infection disease clinics. Rheumatol Int,2013,3(2) :315-318.
  • 4Mert A, Ozaras R, Tabak F, et al. Primary tuberculosis cases presenting with erythema nodosum. J Dermatol, 2004,31 (1) :66 -68.
  • 5Nicol MP, Kampmann B, Lawrence P, et al. Enhanced anti- mycobacterial immunity in children with erythema nodosum and a positive tuberculin skin test. J Invest Dermatol, 2007,127 (9) : 2152-2157.
  • 6Castfiota M, Ricci F, Paradisi A, et al. Erythema nodosum in- duced by kefion celsi of the scalp in a child: a case report and minireview of literature. J Mycoses, 2013,56 (3) : 200-203.
  • 7Schwartz RA, Nervi SJ. Erythema nodosum: a sign of systemic disease. Am Fam Physician,2007,75(5) :695-700.
  • 8Kskouroo T, Drosatou P, Psychou F, et al. Erythema nodosum in children: a prospective study. J Am Acad Dermatol,2001,44 (1) :17-21.
  • 9Harris T, Henderson MC. Concurrent Sweet' s syndrome and er- ythema nodosum. J Gen Intem Med,2011,26(2) :214-215.
  • 10Sullivan R, Clowers-Webb H, Davis MD. Erythema nodosum: a presenting sign of acute myelogenous leukemia. Cutis, 2005,76(2):114-116.

引证文献2

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部